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1. Introduction
One of the most exciting goals in chemical synthesis is the
generation of macromolecules with a well-defined monomer
sequence and dispersity that, at the same time, exhibit
complex functions. Polymer chemistry can be used for the
economic production of synthetic macromolecules. Anionic
polymerization provides access to high-molecular-weight
products with extremely low dispersities; however, this
technique requires the strict exclusion of impurities and
demands inert conditions. An alternative to this method is
controlled living radical polymerization,[1] which yields mac-
romolecules with comparable dispersities and gives easy
access to block copolymers, extending the variety of func-
tional monomers.[2] One group of branched macromolecules
with higher structural accuracy and diversity of functional
groups are the dendrimers, which display a branched macro-
molecular architecture.[3,4] Starting from a multivalent core
molecule, treelike structures have been generated by iterative
synthesis that includes alternating growth and deprotection
steps. A multitude of functionalities have been incorporated
into the core of these structures,[5] as well as in the dendritic
scaffold and the periphery.[6,7] To synthesize polymers with an
even greater variety of functional groups one must also rely
on an iterative synthetic protocol, in which the macromole-
cule is built up on a solid support. The first approaches in this
direction were described by Merrifield for the generation of
oligo- and polypeptides.[8] With this groundbreaking synthetic
method it is now possible to synthesize a large variety of
peptides up to 50–70 amino acids in length with perfect
control over the monomer sequence.[9] To achieve even larger
protein structures, several coupling strategies have been
elaborated for the covalent linkage of these building blocks
through native peptide bonds.[10–13] The principle of solid-
phase synthesis was subsequently adapted for the synthesis of
other biomacromolecules such as nucleic acids[14–16] and
carbohydrates.[17–19] Solid-phase synthesis is amenable to the
production or introduction of nonnatural analogues,[20] for
example peptide nucleic acids (PNAs)[21–23] and locked nucleic
acids (LNAs),[24,25] in addition to the natural monomers to
increase functional diversity. Indeed, more recently efforts
have intensified to build up macromolecules that have only
little structural relationship to their natural counterparts by
employing solid supports and automated synthesizers.[26,27]
Today, these chemical approaches towards well-defined func-
tional macromolecules compete with techniques from molec-
ular biology. Protein engineering is a powerful tool for
expressing natural and de novo designed peptide sequen-
ces.[28] It is even possible to add nonnatural monomers to the
set of naturally occurring amino acids.[29–31] The same holds
true for polynucleic acids.[32] A variety of dye-functionalized
nucleotides have been incorporated into DNA, in particular
for sequencing. As a result of rapid developments in the field
of recombinant DNA technology, a multitude of enzymatic
methods are available to modify, manipulate, and amplify
DNA. The most important enzymes in this context are
kinases, ligases, nucleases, and polymerases. With this set of
enzymes in combination with chemical DNA synthesis almost
any desired polynucleic acid can be produced. Important
techniques include the polymerase chain reaction (PCR) and
the production of plasmid DNA in recombinant bacteria. An
impressive example is the assembly of a complete infectious
viral genome (5386 base pairs (bp)) from chemically synthe-
sized oligodeoxynucleotides (ODNs) utilizing the molecular
biology techniques mentioned above.[33]
In addition to improving synthetic methods to increase the
size and functional complexity of one type of macromolecule,
researchers have developed strategies to combine different
classes of biomacromolecules. This includes posttranslational
modifications of proteins, for instance the synthesis of
glycosylated peptide structures.[34,35] Peptides have also been
covalently connected to ODNs.[36] These are usually referred
to as peptide–oligonucleotide conjugates (POCs)[37,38] or
oligonucleotide–peptide conjugates (OPCs).[39] Only a few
of these covalent nucleopeptides are found in nature.[40] The
majority of POCs were designed to improve the pharmaco-
kinetic properties of therapeutically useful ODNs.
In contrast to these structures, biomacromolecules have
been combined with organic polymers in a covalent fashion.
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Extensive efforts have been devoted to the development of hybrid
structures consisting of biomacromolecules and organic polymers
connected through covalent bonds. While the combination of proteins
and peptides with synthetic macromolecules has been explored in
depth, far fewer examples of nucleic acid/polymer hybrids are known.
In this Review we give selected examples of this exciting class of
materials which can be arranged as linear block copolymer archi-
tectures, as side-chain polymers, or as cross-linked networks. Emphasis
is placed on the fabrication of these materials as well as on their
potential applications in nanoscience, diagnostics, and biomedicine.
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The different architectures are distinguished by how the
biological moieties are connected to the synthetic macro-
molecules. The two building blocks can be arranged in an
alternating manner leading to linear block copolymer top-
ologies (Figure 1a). Alternatively, several peptide or nucleic
acid moieties can be arranged along a polymer backbone
leading to side-chain polymer structures (Figure 1b). The
opposite case, in which several synthetic polymers are
attached to a biomacromolecular backbone, is rarely found
(Figure 1c).[41] Peptides were combined with organic poly-
mers already in the mid-1970s.[42,43] A multitude of excellent
reviews deal with the synthesis[44–52] and supramolecular
organization[53–56] of these hybrid materials.
Much less attention had been paid to the class of
bioorganic hybrids consisting of nucleic acids and synthetic
polymers.[57] In contrast to research on peptide–polymer
hybrids, the first reports of DNA–polymer conjugates go
back only to the late 1980s. Antisense ODNs were grafted
onto a poly(l-lysine) (PLL) backbone. These nucleic acid/
polymer conjugates were employed to inhibit the synthesis of
vesicular stomatitis virus proteins acting as antiviral
agents.[58–60] Since then, numerous applications of these
materials have been realized in addition to gene or ODN
delivery. These range from the purification of biomaterials to
the detection of DNA. In recent years, instead of hydrophilic
polymers like PLL and poly(ethylene glycol) (PEG), hydro-
phobic polymers have been connected to ODNs to generate
macromolecular amphiphiles. Because of microphase separa-
tion, these tend to self-assemble into micellar systems with
nanometer dimensions. These materials thus have promising
potential for applications in the fields of bionanotechnology
and nanomedicine. This Review deals with the synthesis and
potential applications of DNA block copolymers (DBCs).
Different synthetic strategies will be detailed for the produc-
tion of linear DBCs, DNA side-chain architectures, andDNA/
polymer hybrid networks. At the same time, we will highlight
the applications of these DBC architectures, primarily in
biological and biomedicinal contexts but also in the field of
nanoscience. The DBCs in this Review will be discussed in the
order of their structural complexity: DBCs of linear topology
will be described first, followed by side-chain architectures
and cross-linked structures consisting mainly of the latter
structure type.
2. Linear DNA Block Copolymers
2.1. Synthesis
Existing preparative methods for the generation of linear
DBCs allow for the systematic variation of the length and
sequence composition of the nucleic acid segment as well as
the nature of the organic polymer block. Grafting strategies
have proved to be especially successful. In this approach,
prefabricated biological and organic polymer building blocks
are coupled through complementary terminal groups. Two
synthetic schemes can be distinguished: the nucleic acid
blocks can be coupled to the organic polymer segments either
in solution or on a solid support.
For the attachment in the aqueous phase, three different
types of coupling reactions have been employed (Scheme 1).
In the first approach, amino-functionalized ODNs are reacted
with carboxylic acid terminated polymers like PEG,[61,62]
poly(N-isopropylacrylamide) (PNIPAM),[63,64] poly(d,l-
lactic-co-glycolic acid),[65] and poly(p-phenyleneethynyl-
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Figure 1. Illustrations of covalently bonded biopolymers (green circles)
and synthetic (yellow diamonds) polymers. a) Linear block copolymer
composed of biopolymer and synthetic polymer blocks. b) Biomacro-
molecules grafted onto a synthetic polymer backbone. c) Synthetic
polymer side chains on a biomacromolecule backbone.
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ene)[66] to form an amide bond (Scheme 1a). In a second
coupling reaction, disulfide bonds are formed (Scheme 1b).[67]
For this procedure, the ODN must be equipped with a
terminal sulfhydryl group while the PEG is functionalized at
one end with a 2-pyridyl disulfide group. The third ligation
procedure relies on the Micheal addition (Scheme 1c). Also
in this case thiol-modified ODNs are utilized. The PEGs,
however, are modified with either a terminal maleimide or
acrylic acid group.[68] All of these coupling schemes are very
well suited for the generation of DBCs containing water-
soluble organic polymer units. Moreover, since thiol- and
amino-modified ODNs are available from commercial
sources, the block copolymer architectures can be prepared
in a conventional chemical laboratory without expensive
DNA-synthesizer equipment.
The preparation of amphiphilic DBC structures contain-
ing hydrophobic polymers by coupling in solution is rather
difficult because of the different solubility properties of the
individual components. For this reason, strategies have been
developed for grafting polymers onto DNA on a solid support
(Scheme 2). When the ODN is present on the resin, the
nucleotides are still protected, in particular at the phosphate
groups, such that the ODN is soluble in organic solvents in
which the organic polymer moiety can be dissolved as well.
Again, as for solution-phase coupling, different reactions
have been established for attaching the organic polymer to
the ODN. The most straightforward approach is the trans-
formation of the hydrophobic polymer into a phosphorami-
dite polymer by the reaction of a terminal hydroxy group with
phosphoramidite chloride (Scheme 2a). The activated macro-
molecules are then attached to the detritylated 5’-OH group
of the ODN. After incubation with concentrated ammonia for
deprotection and release from the solid support, single-
stranded (ss) DNA diblock copolymers could be obtained, for
example, DNA-b-polystyrene (PS)[69] and DNA-b-poly(prop-
ylene oxide) (PPO).[70] When both termini of the organic
polymer were activated as phosphoramidites, triblock archi-
tectures of the type DNA-b-PEG-b-DNA were also acces-
sible.[71] Alternatively, amide bond formation can be utilized
to graft poly(butadiene) (PB), which has a terminal amino
group, onto immobilized carboxyl-modified DNA (Sche-
me 2b).[72] For the attachment of poly(p-phenyleneethyny-
lene) (PPE), a terminal ethynyl group was coupled with an
iodide unit present in the base of the last nucleotide at the 5’-
end in a palladium-catalyzed Sonogashira–Hagihara coupling
(Scheme 2c).[73]
In all the synthetic routes to DBCs, the nucleic acid
segment usually does not exceed a degree of polymerization
of 50 nucleotides. How can this synthetic limitation be
overcome? The answer is by combining chemical DBC
synthesis with methods from molecular biology. To this end,
the single-stranded ssDBCs described above were employed
as primers for the polymerase chain reaction (PCR)
(Figure 2).[74] The utilization of one ssDBC and a conven-
tional ODN primer yielded double-stranded (ds) DNA
diblock copolymers with extended nucleic acid blocks of the
type A-b-dsDNA (Figure 2, strategy 1), where A denotes an
organic polymer. Employing two ssDBCs with the same
organic block as the forward and backward primers resulted
in double-stranded triblock architectures of type A-b-
dsDNA-b-A (Figure 2, strategy 2). It is important to note
that the PCR process is not only compatible with hydrophilic
polymers like PEG but also tolerates hydrophobic polymers
like PPO and PS as well as thermoresponsive polymers like
PNIPAM. In an extension of this method, two primer DBCs
with different organic blocks led to triblock structures with a
topology of A-b-dsDNA-b-B, where A and B denote differ-
ent polymers. More complex architectures were realized by
employing ssDNA-b-A-b-ssDNA and ssDNA-b-X (A or B
polymer) primers in combination within the PCR; this
Scheme 1. Coupling methods for the synthesis of DNA block copoly-
mers in solution. a) Carboxylic acid terminated polymer coupled with
an amino-functionalyzed ODN. b) Disulfide bond formation between
polymer and ODN thiols. c) Michael addition of a terminal maleimide
on the polymer and thiol-modified ODN.
Scheme 2. Coupling reactions that can be used to prepare DNA block
copolymers on a solid support. a) A hydroxylated polymer was
converted into the phosphoramidite and coupled with 5’-OH group of
DNA in the last step of the DNA synthesis. DMT=dimethoxytrityl.
b) An amino-modified polymer was added to a carboxylic acid modi-
fied DNA on a solid support. c) Pd-catalyzed Sonogashira–Hagihara
coupling of an acetylene-terminated p-conjugated polymer and a 5-
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resulted in pentablock structures, X-b-dsDNA-b-A-b-
dsDNA-b-X.[75] The molecular weights of the nucleic acid
segments easily exceed 1000000 gmol1 and as a result of the
mechanism of the templated polymerization, the products are
monodisperse. In this light, the usage of ssDBCs within the
PCR process pushes the limits in the synthesis of block
copolymers in terms of molecular weight as well as structural
accuracy.
2.2. Supramolecular Strucures
In the era of nanoscience, the assembly of structures on
the nanoscale and the presence of several levels of organ-
ization are important criteria for synthesizing compounds
with functional and material properties. A few years ago
Seeman and Rothemund reported wholly unprecedented
designed self-assemblies of DNA.[76,77] Their groundbreaking
work gave birth to an entire field of nucleic acid nano-
architectures.[78,79] Nanostructures constructed of DBCs offer
several unique opportunities in this respect. The aggregation
behavior of the bioorganic hybrid structures can be controlled
either by the recognition of the nucleic acid moiety or by the
interactions of the organic polymer units and combinations
thereof.
Supramolecular polymers have gained increasing interest
in recent years because of the dynamic properties of these
materials resulting from the reversible bonds holding the
polymeric chain together.[80] DBCs are an excellent example
of this type of material. Well-defined block-type structures
can be assembled from ssDBC building blocks (Figure 3).
One example is the generation of triblock structures from two
ssDBCs with complementary sequences by hybridization and
thus duplex formation (Figure 3a).[71] Extension of this
concept resulted in pentablock architectures through the
assembly of a single-stranded triblock structure of the type
DNA-b-PEG-b-DNAwith two equivalents of single-stranded
diblock structures of the type DNA-b-PEG (Figure 3b).
These structures were characterized by PAGE (Figure 3d)
and MALDI-TOF mass spectrometry (Figure 3e). Even
larger one-dimensional polymer assemblies were achieved
when two single-stranded self-complementary triblock struc-
tures were employed with a DNA-spacer-DNA topology
(Figure 3c).[81] Polymer formation was evident by the
increased viscosity of the reaction mixture compared to
solutions of nonpolymerizing analogues. Molecular weights
can be easily controlled by varying the ratios of DNA hybrid
monomers because excess monomer acted as effective “chain
terminators”.
Not only the nucleic acid units but also the organic
polymer segments are well suited to inducing superstructure
formation. This is especially true for hydrophobic polymer
segments, as they tend to undergo microphase separation in
aqueous medium. Amphiphilic DBCs form micellar aggre-
gates exhibiting a hydrophobic polymer core and a corona of
ssDNA. In the case of ssDNA-b-PS, these micelles were
formed with the help of a cosolvent, and the average
diameters of the aggregates could be adjusted by varying
the lengths of the nucleic acid units.[69] The fabrication of
micelles from DNA-b-PPO was even simpler because the
polymer exhibits a low glass transition temperature (TG=
70 8C), such that micelles form after a simple heating and
cooling procedure. It should be pointed out that the formation
of such DNA/polymer hybrid nanoparticles is experimentally
much less demanding than the generation of complex nano-
structures exclusively based on nucleic acids.[82,83]
The structural properties of the spherical DBC aggregates
can be altered by hybridization. While hybridization of DBC
micelles with short ODNs complementary to the corona did
not change their spherical shape (Figure 4a), Watson–Crick
base-pairing with long templates induced the formation of
rodlike aggregates (Figure 4b).[84] The sequence composition
of the templates was selected to encode the complement to
that of the DNA micelle corona multiple times. During
hybridization, a double helix formed from which a PPO
Figure 2. Schematic representation of molecular biological strategies
like PCR for the preparation of di- and triblock copolymers with larger
DNA units. Strategy 1: DNA block copolymer (forward primer, F) and
DNA (backward primer, B) yield PEG-b-dsDNA. Strategy 2: Two PEG-b-
DNA primers produce triblock copolymer PEG-b-dsDNA-b-PEG
(adapted from Ref. [74]).
Figure 3. Generation of multiblock structures by DNA hybridization.
a) Hybridization of two complementary DNA block copolymers yields a
triblock architecture. b) A pentablock architecture composed of triblock
and diblock DBCs. c) One-dimensional polymeric assemblies consist-
ing of two complementary triblock copolymers. d) Polyacrylamide gel
of triblock and pentablock copolymers; lane 1: ssDNA-b-PEG-b-
ssDNA, lane 2: dsDNA-b-PEG-b-dsDNA, lane 3: PEG(5kDa)-b-
dsDNA-b-PEG-b-dsDNA-b-PEG(5kDa), lane 4: PEG(20kDa)-b-dsDNA-
b-PEG-b-dsDNA-b-PEG(20kDa). e) MALDI-TOF mass spectrum of the
pentablock copolymer with 5 kDa PEGs shown in lane 3 in (d)
(adapted from Ref. [71]).
A. Herrmann and M. KwakReviews
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moiety projected every 22 nucleotides. This led to the parallel
arrangement of two double helices “glued” together by the
hydrophobic interactions of the organic polymer units. Even
the lengths of the rodlike aggregates could be controlled by
the length of the template molecules.
In addition to small micellar structures with diameters of
up to 45 nm,[85] DBCs have been used to form larger objects.
When 12-mer ODNs were attached to PB, vesicles with an
average diameter of 80 nm were found along with higher
ordered vesicles exhibiting a closed DBC double-layer
membrane.[72] These structures were employed to prepare
ODN-modified surfaces on which bacterial biofilm formation
was studied.[86]
2.3. Applications and Functions
2.3.1. Nanoscience
Linear DBCs are not only suited for the construction of
supramolecular and nanoscopic structures alone; owing to the
self-recognition properties and biological role of DNA, the
resulting aggregates can also be easily equipped with extra
functionality. One example, which makes use of the fact that
DBCs are macromolecules with coded information, is DNA-
templated chemistry[87] in DBC micelles (Figure 5). For this
purpose, ssDBC aggregates were hybridized with reactant
DNA bearing functional groups. Owing to the close proximity
of these groups within the micellar confinement, several
organic reactions like the Michael addition and amide bond
formation could be carried out sequence-specifically within
the programmable nanoreactors. It is even possible to
spatially define the transformations to take place either at
the surface of the micelles (Figure 5a) or within the interior of
the bioorganic particles shielded from the environment
(Figure 5b). The location of the reaction can be controlled
by attaching the reactants to either the 5’- or the 3’-ends.
DBC micelles can also be employed as scaffolds for
enzymatic conversions. In contrast to the thermostable
polymerases described in Section 2.1 for the preparation of
dsDBCs, the polymerase terminal deoxynucleotidyl trans-
ferase (TDTase) does not need a template for adding any of
the four nucleoside triphosphates (dNTPs). DBC micelles
were incubated at 37 8C with this enzyme and dTTP. With
increasing reaction time, the size of the DNA nanoparticles
increased through the addition of polyT segments to the
DBC. The diameter of the nanoscale objects could be
gradually adjusted from 10 to 23 nm over a reaction time of
16 h. This was the first demonstration that the size of
nanoparticles could be increased with the help of an
enzyme.[85]
In another example DBCs were employed to generate
organic/inorganic particle networks. DNA-b-PS micelles were
hybridized with DNA-modified gold nanoparticles exhibiting
the complementary sequence on the surface.[69] The resulting
composites proved that DBCs can be used to generate higher
ordered structures through sequence-specific hybridization
with other DNA-modified nanomaterials. Moreover, sharp
melting temperatures were detected for their disassembly,
which was explained by a cooperative melting model.
The Watson–Crick base-pairing of DBCs is not limited to
the generation of nanosized systems; the double-helix for-
mation has also been utilized for the preparation of micro-
capsules. Alternating layers of T30-b-PNIPAM and A30-b-
PNIPAM were assembled on silicon templates. After disso-
lution of the core and functionalization of the surface with
PEG, stable microcapules were obtained that might be
exploited for the delivery of siRNA and anticancer drugs.[88]
2.3.2. Diagnostics
When linear DNA block copolymers were utilized for
DNA detection, the nucleic acid units were coupled to light-
emitting oligomers or polymers. One kind of probe architec-
ture consists of a central fluorene emitter unit onto which two
identical ODNs are attached to form a so-called twin probe
(Figure 6a). This conjugate was applied in homogeneous
DNA detection assays. By a mechanism that relies on the
Figure 4. Representation and AFM images of PPO-b-DNA aggregates.
a) Hybridization of the spherical ssDNA micelle (blue) with the
complementary DNA (red) generates dsDNA-b-PPO nanostructures.
b) Hybridization of the spherical ssDNA micelle with a long template
results in rodlike aggregates. Scale bars in images: 200 nm (adapted
from Ref. [84]).
Figure 5. DNA-templated synthesis a) on the surface of a PPO-b-DNA
micelle and b) in the core of the micelle. Red and green spheres
correspond to reacting functional groups, and yellow sticks represent
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dequenching of the fluorescence upon hybridization, com-
plementary target sequences as well as single-nucleotide
polymorphisms (SNPs) could be detected. The selectivity of
the twin-probe system is remarkable when one considers that
it contains only a single emitting species and does not require
dual labeling. DNA detection was realized with concentra-
tions ranging from 103 to 108m.
Other DBC probe architectures, however, rely on labeling
with several light-emitting entities. An excellent example is
the conjugated polymer molecular beacon. This consists of a
ssDNA unit functionalized at one end with a negatively
charged, highly emissive PPE, while the other end is attached
to a quencher moiety (Figure 6b).[73] The DNA sequence was
selected to form a stem–loop structure. In this configuration,
the conjugated polymer is in close proximity to the quencher,
leading to complete suppression of the emission of the
conjugated polymer by an effect referred to as superquench-
ing.[89] In the presence of a complementary target sequence,
hybridization results in a separation of the polymer and
quencher, and thus to light emission from the conjugated
emitter. Unfortunately, this promising probe has not been
evaluated with respect to its sensitivity and selectivity. A
combination of the twin probe and the conjugated polymer
molecular beacon architectures was realized by attaching two
stem–loop structures with terminal quenchers to the two ends
of a negatively charged PPE polymer (Figure 6c). At target
concentrations of 4  106m, the fluorescence signal from the
conjugated polymer was two orders of magnitude higher than
the signal achieved with a noncomplementary sequence. Even
SNP detection was possible with such a probe.[66]
2.3.3. Biomedicine
In addition to diagnostics, linear DBCs have been
successfully applied in the field of biomedicine. Oligonucleo-
tides (mainly aptamers, antisense ODNs, and small interfer-
ing RNA (siRNA)) are now under active investigation as new
potential drugs because of their extremely high selectivity in
target recognition. All of them, however, display the short-
comings of short half-life in vivo because of either low
stability towards nucleases, which are present in plasma and
inside the cells, or rapid excretion on account of their
relatively low molecular weights. Furthermore, their negative
charge prevents easy internalization into cells. One way to
tackle these problems is to functionalize pharmaceutically
active nucleic acids with PEG.[93] Direct coupling of PEG[90] or
coupling through a linker molecule[91] has resulted in
increased stability of oligonucleotides towards enzymatic
degradation, prolonged plasma permanence, and enhanced
penetration into cells by masking the negative charges of
ODNs. One DBC drug already commercialized in 2004 is a
PEGylated 28-mer aptamer, PEG-aptanib, which was
approved by the FDA for the treatment of age-related
macular degeneration of the retina. This DBC drug consists of
a branched PEG (40 kDa) attached to the ODN through a
pentylamino linker.[92]
For the successful delivery of antisense DNA, ODNs were
likewise conjugated with PEG. However, for successful
delivery they were complexed with positively charged poly-
electrolytes. As a result, so-called polyion complex
micelles[67,68] and the synonymous polyelectrolyte complex
micelles[61,94] were obtained with a core–shell structure. The
nucleic acid moiety and the positively charged polyelectrolyte
formed an inner core through ionic interactions, while the
PEG chains constituted the shell. For effective delivery in
HuH-7 cells, the DBCs were designed to contain a disulfide
linkage between the ODN and the PEG. This linker resulted
in better antisense effects than the utilization of an acid-
cleavable connecting element. Another important parameter
is the type of polyelectrolyte. Poly(l-lysine)-containing
micelles were shown to be less efficient than poly(ethylene-
imine) (PEI), which indicated that the DNA-b-PEG was
successfully transported from the endosomal compartment
into the cytoplasm thanks to the buffering effect of PEI. Upon
cleavage of the disulfide linkage hundreds of active antisense
ODNs were released into the cell interior in response to high
glutathione levels in the cytoplasmatic compartment.[67] In a
similar set of experiments, the internalization of the polyion
complex micelles into HuH-7 cells was promoted by the
attachment of a lactose targeting unit at the other terminus of
the PEG block, that is, opposite to the ODN; this modifica-
tion led to increased antisense activity.[68]
Besides antisense delivery in vitro, polyelectrolyte com-
plex micelles were successfully employed to suppress onco-
genes in test animals. A c-raf antisense ODN formulation,
which was intravenously administered to nude mice bearing
human lung cancer tumors, exhibited significant antitumor
activity. Moreover, the DBC-containing micelles showed
higher accumulation levels than the non-polymer-modified
ODN in the solid tumor region.[61] In previous experiments
the same group demonstrated a significant reduction in tumor
growth when c-raf antisense ODNs were employed in
polyelectrolyte complex micelles injected directly into the
tumor region.[94]
More recently the same electrostatically induced DBC
aggregates were utilized for the therapeutic delivery of
siRNA.[62,95] In the context of anti-angiogenic gene therapy,
PEG-conjugated vascular endothelial growth factor (VEGF)
siRNA complexed with PEI was shown to inhibit VEGF
Figure 6. Representation of DBC-based DNA detection. a) Twin-probe
reporter with a fluorescence emitter in the middle. b) Molecular
beacon with a light-emitting polymer. c) Beacon with a stem–loop
DNA structure at either end of the polymer. Q=quencher moiety.
A. Herrmann and M. KwakReviews
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expression in the tumor tissue and suppress tumor growth in
an animal model without any detectable inflammatory
response.[95] The micelles were administered to mice intra-
venously and intratumorally. After the intranvenous injec-
tion, enhanced accumulation of the nanosized DBC particles
was detected in the tumor region. This study demonstrated
the feasibility of using DBC micelles as a potential carrier for
therapeutic siRNA in local and systemic treatment of cancer.
As with DBC nanoparticles assembled by means of
electrostatic interactions, amphiphilic DBCs that form nano-
particles by microphase separation have also been employed
for drug-delivery purposes. In this case the DNA did not serve
any biological function but instead facilitated the extremely
convenient generation of multifunctional particles. These
nanoscale objects were equipped with targeting units that
recognize cell surface receptors of Caco-2 cells, a cancer cell
line (Figure 7). Specifically, folic acid was coupled to a DNA
sequence complementary to that of the micelle corona, such
that these functionalities could be introduced by a simple
hybridization procedure (Figure 7a). In a second step a
hydrophobic anticancer drug, doxorubicin, was loaded in the
hydrophobic core of the DBCmicelles (Figure 7b). With both
units acting in concert, the cancer cells were efficiently
killed.[96] Prior to the drug-delivery experiment it was
demonstrated that an increasing number of targeting units
on the micelle surface facilitate internalization of the DBC
nanoparticles by receptor-mediated endocytosis. In contrast,
when the folic acid moieties were directed into the interior of
the nanosized objects, they were not recognized by the cells.
The internalization process was monitored by confocal laser
scanning fluorescence microcopy with DBC particles that
were fluorescently labeled by the same convenient hybrid-
ization procedure as that for introduction of the targeting
units. Since it is easy to functionalize DBC micelles, these
materials qualify to be used as a combinatorial platform for
the testing and high-throughput screening of drug-delivery
vehicles.
The nondirected internalization of DBC systems, that is,
without external targeting units, was studied as well. In
particular, the question of whether the shape of the nanoscale
objects influences uptake was addressed. For that purpose,
Caco-2 cells were incubated with ss and ds spherical DBC
particles as well as with the rodlike particles described in
Section 2.2 (Figure 4). Although all the particles were com-
posed of the same DBC materials, the rodlike structures were
internalized one order of magnitude more efficiently than
their spherical counterparts.[97] Such experiments are impor-
tant because they suggest that the shape of a nanoparticle
might be an additional important design criterion for drug-
delivery vehicles.
3. DNA Side-Chain Polymers
As mentioned in the introduction, two different classes of
DNA side-chain polymers are known. The structures that will
be discussed first consist of a dsDNA backbone onto which
organic polymers are grafted. The first structures with such an
architecture consisted of bacteriophage T4 (166 kbp) or l
phage DNA (48.5 kbp) onto which polyacrylamide or poly(N-
isopropylacrylamide) (PNIPAM) were attached.[98,99] The
DNA and the polymer were connected by an intercalator
that consisted of a phenazinium derivative functionalized
with acrylic acid. The graft architecture was then obtained by
polymerization of acrylamide or N-isopropylacrylamide and
the polymerizable intercalator as co-monomer in the presence
of DNA. However, this strategy does not lead to the covalent
attachment of the biological and the organic segments. For
this purpose, psoralen was investigated; this intercalator is
known to undergo cycloaddition with nucleobases. When a
psoralen-containing vinyl monomer was employed under
experimental conditions similar to those described above,
covalent coupling of the acrylic acid polymers and the DNA
was realized upon irradiation with UV light.[100,101] Subse-
quently this synthetic strategy was slightly refined. Instead of
the incorporation of numerous intercalating moieties along
the main chain of the synthetic polymer unit, semitelechelic
PNIPAMs terminated with a psoralen group were generated.
This made it possible to prefabricate the organic polymer
building block, and it was subsequently grafted onto the
dsDNA by irradiation with UV light.[102]
Like the linear DNA-b-PNIPAM polymers,[101] these graft
architectures were employed for thermoprecipitation
(Figure 8). In this application the DNA backbone acted as
the recognition site while the PNIPAM side chains induced
thermoresponsive properties. One conjugate was utilized for
the capture of ethidium: about 95% of this DNA-binding
genotoxin could be removed from a highly dilute solution
(3 ppm). Besides the thermally induced affinity separation of
small molecules, such graft architectures were used to isolate
DNA-binding proteins. Hind III, an endonuclease, was suc-
cessfully coprecipitated as a DNA-PNIPAM conjugate by the
addition of glycerin, which decreases the lower critical
solution temperature (LCST: the critical temperature below
which a mixture is miscible in all proportions).[99] It should be
noted that this experiment was carried out in Mg2+-free
buffer. In the absence of this cofactor, Hind III binds DNA
strongly but does not show any nuclease activity. A DNA-
PNIPAM conjugate that worked even more efficiently was
based on a DNA-block-brush architecture (Figure 8).[41] It
Figure 7. Diagram of the drug-delivery system based on DNA block
copolymer micelles. a) The micelle made up of single-stranded DNA is
hybridized with the folic acid conjugated to complementary DNA (red
sphere, blue strand) to equip the nanoparticle surface with targeting
units. b) The hydrophobic anticancer drug, doxorubicin (green sphere),
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consisted of one nucleic acid segment with PNIPAM attached
as side chains and another segment of pristine dsDNA
encoding the so-called TATA box, which is involved in the
initiation of transcription in eukaryotes. When a mixture of
TATA box binding protein (TBP) and bovine serum albumin
(BSA) that does not show any affinity to DNAwas incubated
with such a block conjugate, rapid and selective precipitation
of bound TBP was achieved through temperature modula-
tion. The TBP purified under homogenous conditions exhib-
ited a purity of more than 90% as estimated from SDS-PAGE
analysis.
The other type of DNA side-chain polymer consists of a
synthetic polymer backbone onto which ODNs are grafted
(Figure 9). These bioorganic hybrid structures are accessible
by two general synthetic strategies. The first relies on the
functionalization of a prefabricated synthetic polymer back-
bone with ODNs (Figure 9a), while the second is based on
attaching ODNs to a polymerizable unit, which is subse-
quently incorporated into the polymer main chain by
copolymerization (Figure 9b). With regard to the first
approach, a multitude of synthetic procedures have been
elaborated to attach the ODN to the polymer backbone. A
copolymer of polyacrylic acid (PAA) could be modified with
amino-terminated ODNs as side chains by amide bond
formation employing 1-ethyl-3-(3-dimethylaminopropyl)car-
bodiimide (EDC) as the coupling reagent.[103] In a similar
approach amino-functionalized ODNs were reacted with a
poly(N,N-dimethylacrylamide) copolymer that contained
activated ester groups to establish stable amide bridges
between the polymer backbone and the nucleic acid
units.[104] RNA units could be coupled to a poly(l-lysine)
backbone through the formation of N-morpholine rings. This
procedure included periodic acid oxidation and cyanoboro-
hydride reduction of the 3’-end ribose unit.[105] In addition to
approaches that rely on coupling the two segments in
solution, synthetic routes have been elaborated that rely on
grafting onto the solid support. For instance, after their solid-
phase synthesis the ODNs were left on the solid support. The
detritylated 5’-OH groups of the ODNs were reacted with an
organic polymer carrying multiple phosphoramidite groups
along its backbone.[106,107] This approach was also used to
prepare block-brush copolymers since the main chain was
built up by sequential ring-opening metathesis polymeri-
zation (ROMP) of differently functionalized norbornene
monomers. Another possibility to generate DNA side-chain
polymers on the solid phase relied on immobilizing the
synthetic polymer backbone on glass beads.[108] The hydroxy
groups present on the controlled pore glass surface were
reacted with alternating copolymers containing maleic anhy-
dride units so that a covalent ester bond between the support
and the polymer formed. The remaining anhydride structures
were utilized to bind a 5’-trityl-protected mononucleotide
carrying an aminoalkyl spacer by means of bond formation
that acted as an initiator of ODN synthesis. Because the ester
and the amide connections have different stabilities, the DNA
side-chain polymers could be selectively cleaved from the
solid support after completion of the DNA synthesis by
treatment with base. These two strategies lead to drastically
different grafting densities: Performing the grafting reaction
as the final step of conjugate synthesis resulted in an average
of five ODNs per polymer backbone,[107] while DNA synthesis
on the immobilized polymer initiators yielded up to 109
nucleic acid units per polymer backbone.[109] It should be
mentioned that in these solid-phase approaches the ODNs
have different attachment sites. While the first route leads to
conjugates with the ODN connected to the polymer chain at
the 5’-end, the latter procedure results in hybrids with the
ODN attached at the 3’-end.
A conceptually different approach to generating DNA-
polymer hybrids with ODNs as side chains consists of the
copolymerization of ODNmacromonomers. For this purpose,
the ODN was functionalized with a polymerizable group
either by coupling amino-terminated ODNs to methacrylic
acid in solution[110] or by attaching an acrylamide-functional-
ized phosphoramidite to the ODN sequence on the solid
phase.[111,112] A variety of vinyl ODN macromonomers under-
went radical polymerization with acrylamide and N-isopro-
pylacrylamid to yield the corresponding side-chain poly-
mers.[112–115] Moreover, a variety of ODN-containing side-
chain polymers were generated for electrochemical and
optical sensors. However, these structures were poorly
soluble and they could not be thoroughly characterized.[116–120]
Figure 8. Diagram of affinity precipitation and separation of the DNA
binding protein (TBP) using a thermoresponsive polymer. After the
binding of TBP on the TATA box, the solution was heated to precipitate
the assembled aggregate that formed as a result of the thermally
induced phase transition of PNIPAM side chains (adapted from
Ref. [41]).
Figure 9. Preparation of side-chain polymers with grafted DNA.
a) DNAs are attached to the functional groups along the polymer
backbone. b) Copolymerization of a monomer and a nucleic acid
monomer.
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The arrangement of several ODN units along a single
polymer chain has important consequences for base-pairing
properties when two of these architectures with complemen-
tary sequences are hybridized. It has been found that the
melting curves are sharper than those of structures obtained
from the hybridization of complementary untethered ODNs
in solution. Furthermore, the melting temperatures are
shifted to higher values. This characteristic melting behavior
was the subject of several physical studies.[121,122] Most
important is that these properties, which originate from
multimerization of ODNs along a polymer chain, could be
exploited for highly selective DNA detection systems. This is
especially true for the sharp melting curves that allow
resolution enhancement for the detection of single base
mismatches in other nanoparticle systems like DNA-modified
gold particles.[123–125]
A similar system was realized with ssDNA side-chain
polymers linked to a PNIPAM backbone.[126] When the
dissolved materials were heated above TLCST, they tended to
form core–shell particles with the PNIPAM in the interior and
the nucleic acid units at the surface. When the particles were
hybridized with the complementary sequences, the colloidal
stability of the particles decreased, leading to the formation of
particle aggregates at defined salt concentrations (Fig-
ure 10a). This aggregation was monitored by measuring the
absorbance at 500 nm. Since in this case the particles were not
connected by means of bridging ODNs, the mechanism of
aggregation was different from that of ODN-functionalized
gold nanoparticles. One drawback of the DNA-PNIPAM
side-chain polymer system was the high detection limit, in the
mm range. Much more sensitive were the detection systems
based on block graft architectures with a polynorbornene
backbone.
When, in addition to ODNs, ferrocene units, were
attached to the polymer main chain, the resulting conjugates
could be employed in a three-component sandwich-type
electrochemical detection strategy (Figure 10b).[107] After
immobilization of a probe sequence, the electroactive DNA
side-chain polymer and the target DNA exhibiting comple-
mentarity to both sequences were added and the redox signal
was measured. The sensitivity of that signal was as low as
100 pm.
In a different approach, not one but two side-chain
polymers were employed in a sandwich-based DNA detection
assay (Figure 10c). One DNA side-chain polymer was
employed as a capture ODN, and after the addition of the
target DNA the second side-chain architecture was used as
the detection polymer. The fluorescence intensity after an
enzyme-catalyzed conversion of a fluorogenic coumarin
derivative served as the final readout of the assay. It was
demonstrated that the utilization of DNA side-chain archi-
tectures induced a 50-fold increase in sensitivity over that
obtained with the nontethered pristine ODNs used as a
reference. The detection limit of these assay configurations
lies around 0.1 pm.[127,128]
For DNA detection purposes, DNA side-chain polymers
with a conjugated backbone have also been employed.[117]
This experimental setup was special in that the poly(oxadia-
zole–fluorene) derivatives, which served as the backbone of
the DNA side-chain architectures, were immobilized on a
glass surface. Light-directed synthesis of the probe DNAwas
performed directly on the chip, that is, on the conjugated
polymer coating (Figure 10d). For the design of the con-
jugated polymer, special attention was paid to the stability of
the material because of the harsh conditions required in DNA
synthesis. For the DNA detection assay, a dye-labeled target
was hybridized on the chip. The fluorescence energy transfer
from the conjugated polymer to the dye was measured as a
read-out. The detection limit of these conjugated polymer–
DNA chips was 100 pm.
Figure 10. Examples of DNA detection methods based on DNA–
polymer conjugates. a) Hybridization of ssDNA–PNIPAM aggregates
reduces their colloidal stability. Detection of particle aggregation by
optical absorption (adapted from Ref. [126]). b) Electrochemical detec-
tion of DNA employing a DNA–ferrocene–polymer hybrid (adapted
from Ref. [107]). c) Sandwich method of enzyme-linked oligosorbent
assay. The enzymatic reaction induces the fluorescent signal (adapted
from Ref. [127]). d) DNA detection using a light-emitting polymer
immobilized on a chip surface (adapted from Ref. [117]) Black dia-
monds: amino groups as attachment points for ODNs; orange
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DNA side-chain polymers have been employed exten-
sively as antisense reagents as well. The advantage of coupling
ODNs to a positively charged PLL backbone is that the
hybrid can be more easily introduced into intact cells than
pristine DNA. A 15-mer ODN-PLL side-chain architecture
complementary to the initiation region of the mRNA of
vesicular stomatitis virus (VSV) N-protein specifically inhib-
ited expression of VSV proteins. Moreover, antiviral activity
was exhibited when the DNA side-chain polymer was added
in cell culture medium at doses as low as 100 nm.[58] Antiviral
activity against human immunodeficiency virus type 1 (HIV-
1) was evaluated through a similar approach.[129] Two regions
of the viral RNAwere selected as targets for antisense ODNs
and incorporated into side-chain architectures. These experi-
ments demonstrated that the first step of the viral infection,
reverse transcription and the synthesis of proviral DNA,
could be prevented in cell culture.
When instead of PLL, PNIPAM was employed as the
synthetic polymer backbone of DNA side-chain polymer
architectures, the antisense activity of these conjugates could
be controlled by temperature. In initial experiments it was
demonstrated that DNA-PNIPAM side-chain polymers bind
complementary RNA sequence specifically at 27 8C, which is
below their TLCST (33 8C). In contrast, at 37 8C, which is still
below the ODN melting temperature, binding to the com-
plementary sequences was significantly reduced, probably
because of the restricted spatial accessibility of the ODNs
induced by the coil to globule transition.[115] This character-
istic recognition behavior of the ODN side-chain polymer was
utilized in an in vitro transcription translation system for the
stimulus-responsive regulation of gene expression. At 27 8C
expression levels were significantly reduced, similar to that
when pristine antisense ODNwas employed. Above TLCST the
presence of the antisense DNA side-chain polymer did not
affect expression levels, whereas the control ODN induced a
significant antisense effect.[113] Moreover, it was demonstrated
that the antisense activity of the DNA-PNIPAM conjugate
was regulated rapidly as a result of the conformational change
of the PNIPAMbackbone. The globule state of theDNA side-
chain polymer increases stability against nucleases. At 37 8C
complete resistance against nuclease S1 was observed.[114]
4. Cross-Linked Networks of DNA and Polymers
DNA side-chain polymers can be transformed into cross-
linked structures by two different methods. When two of these
conjugates with complementary sequences are hybridized,
networks can be obtained.[104] The second strategy employs
cross-linking DNA. To this end, a DNA side-chain polymer
was mixed with an ODN that twice encoded the comple-
mentary sequence of the nucleic acid/polymer hybrid.[104] Why
are such cross-linked polymer architectures or networks
important? In recent years hydrogels have attracted consid-
erable attention because they can react to changes in their
environment. This stimulus responsiveness, which in the
context of polymer networks is primarily associated with
swelling and deswelling of the material, can be elicited by
changes in temperature, pH, or photon flux. In the case of the
DNA hydrogels mentioned above, thermoreversible materi-
als were obtained. While at low temperatures highly swellable
networks were produced, at elevated temperatures the net-
works disaggregated and dissolved.[104] In other hydrogel
systems stimuli-induced phase transitions have been
exploited, for example, for controlled drug release from
nanosized[130] and macroscopic networks.[131] A more specific
trigger to induce changes in the physicochemical properties of
hydrogels is the recognition of biomolecules. Polymer net-
works containing a covalently incorporated antibody Fab
fragment showed reversible volume changes upon incubation
with the antigen fluorescein.[132] Another antibody-containing
hydrogel, when applied as a membrane, exhibited pulsatile
permeation of a macromolecular model drug in response to
stepwise changes in the antigen concentration.[133] Similar to
the specific recognition of antibodies and antigens, DNA
hydrogels react to base-pairing of complementary sequences.
Both shrinking and swelling of DNA hybrid networks were
achieved by the addition of an ODN. Inspired by molecular
beacons, Maeda and Murakami incorporated stem–loop
structures as cross-links into a polyacrylamide matrix. It
must be pointed out that the 3’- as well as the 5’-ends were
connected to the synthetic polymer.[134] When these networks
were hybridized with DNA sequences complementary to the
loop structure, the hydrogels expanded. This volume increase
can be explained by the concerted disintegration of the loop
structure during the hybridization event and the associated
longitudinal extension of the cross-links. In contrast, when the
sequence incorporated into the hydrogel was designed so as to
contain no secondary structure, addition of the complemen-
tary DNA sequence led to contraction of the hydrogel. This
deswelling is due to the fact that dsDNA is generally shorter
than ssDNA. It is important to note that the sequence
responsiveness of these networks is sensitive even to single
base mismatches. In a similar approach the same group
demonstrated the shrinking of semi-interpenetrating net-
works of DNA–polymer hybrids.[135]
While these volume changes are irreversible, DNA
hydrogels with convertible mechanical states induced by
hybridization can be generated as well. The basis for this
switching process relies on DNA sequences that have been
developed in the context of DNA-fueled machines.[136,137]
Translated to polymer networks, the DNA side-chain poly-
mers were hybridized with a cross-link strand (Figure 11). The
special feature of this cross-link sequence was that besides
encoding the complement of the DNA–polymer hybrids, it
contained an additional sequence. In the course of cross-
linking by hybridization an overhang or so-called “toehold”
was generated. When the full complement to the cross-linking
strand including the toehold, that is, the removal strand, was
added, the cross-links disintegrated.[112] This represents a
rather significant step forward in the area of stimulus-
responsive hydrogels since the reversal of cross-linking is
induced simply by the addition of DNA without the need to
change external parameters like temperature, pH, or salinity.
Because of the attractiveness of such a mild stimulus for drug
delivery, Simmel and co-workers demonstrated the controlled
trapping and release of quantum dots in these DNA hydrogel
systems by employing single-molecule fluorescence micros-
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copy and fluorescence correlation spectroscopy.[138] A similar
hybridization strategy was employed to reversibly change the
mechanical properties of a DNA hybrid network without fully
disintegrating the gel. In this case not two but three pristine
DNA strands were needed. First, a cross-linking DNA of
greater length (80 bases) than that used in the previous
example was added to the DNA side-chain polymer (20-mer
ODN grafts at both ends) to form the network. Then a so-
called fuel strand (50 bases) was introduced that transformed
the middle single-stranded region of the cross-linking strand
into dsDNA and at the same time generated a 10-base
toehold. As a result of hybridization, the cross-link stiffened
and compressive forces were generated leading to tension in
the polymer chains. When the removal strand was added, it
fully hybridized with the fuel strand beginning at the single-
stranded toehold and the gel reverted to its initial state
without disintegration of the network architecture. In this
manner, changes in stiffness greater than a factor of three
were observed.[111]
But such hybrid networks are not the only DNA-contain-
ing hydrogels known; networks consisting exclusively of
DNA have also been produced. This was done by chemical
cross-linking of salmon testes DNA. As a cross-linking agent
ethylene glycol diglycidyl ether was employed.[139] Character-
istic of these gels was a discontinuous volume transition upon
addition of acetone to the aqueous DNA hydrogel. At 63%
acetone composition 15-fold shrinking of the material was
observed relative to its initial volume.[139] The dependence of
the volume transition of such hydrogels on sodium and
calcium ions was studied. The gel volume at high Na+ and low
Ca2+ concentrations decreased with increasing Ca2+
uptake.[140]
An alternative method for generateing cross-linked DNA
networks is PCR. In a two-step process two Y-shaped
trisoligonucleotides in combination with a double-stranded
template were transformed into hydrogels with segment
lengths between the branching points ranging from 70 to
1062 nucleotides.[141]
Yet another technique to prepare all-DNA hydrogels
consists of exploiting enzyme-catalyzed assembly.[142] The
building blocks of this type of hydrogel were branched DNA
molecules consisting of three or four interpenetrating nucleic
acid strands and containing complementary sticky ends. The
X-, Y-, and T-shaped units were hybridized, and covalent
phosphodiester bonds between them were realized with T4
DNA ligase. During the process of gel formation, which was
carried out under physiological conditions, drugs and even
live mammalian cells could be encapsulated. Applications for
these hydrogels were proposed including controlled drug
delivery, tissue engineering, 3D cell culture, and cell trans-
plant therapy. In a continuation of this work, networks were
produced with a whole gene bridging the DNA branching
points. Functional proteins were produced within the DNA
hydrogels with an in vitro transcription/translation system.
Remarkably, the production efficiency was 300 times higher
than that of current solution-based approaches.[143]
Because of their C3-symmetrical structure and low
number of constituents (three ODNs), Y-shaped building
blocks have been further exploited to form responsive DNA-
based hydrogels.[144] A modified three-armed DNA structure
can quickly and reversibly form a hydrogel upon a simple
change of pH, which induced interlocking terminal cyrosine-
rich DNA stretches.
5. Conclusions
The combination of precise control over structure, molec-
ular weight, and chemical function has long been a major goal
in chemical synthesis and materials chemistry. Block copoly-
mers, especially those containing biological macromolecules,
represent an important step towards achieving this goal.
Peptide/organic polymer hybrids have already been widely
explored for these purposes, but the relatively recent devel-
opment of DNA block copolymer materials holds even
greater promise. DNA itself is among the most extensively
studied biomacromolecules, and a broad range of biological
and chemical techniques can be used to generate monodis-
perse DNA segments of virtually any length and sequence
composition. As elaborated above, numerous methods exist
for coupling this molecule to hydrophilic and hydrophobic
polymers, both in solution and on a solid support. The unique
self-recognition properties of DNA allow direct application,
for instance in antisense RNA delivery and sensitive DNA
detection, as well as specific and facile functionalization for
templated reactions and particle recognition. Likewise, DNA
hybridization can be harnessed to elaborate more compli-
cated structures, from multiblock copolymers to multilayered
vesicles and reversible hydrogels. Without question, the
potential applications for this exciting class of materials are
many, whether in drug delivery or the build-up of well-defined
nanostructures. However, much more investigation is needed.
Moreover, further synthetic strategies should be explored to
expand the variety of available hybrids and architectures. In
light of the significant progress that has been made already in
the past decade, practical applications for these materials are
likely already on the horizon.
Figure 11. Schematic diagram of reversible DNA cross-linked polyacryl-
amide hydrogel. The overhang of the cross-linker DNA enables the
reversible disintegration of the network by the hybridization of removal
strand, which is complementary to the cross-linker strand in full length
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